Ginkgo Bioworks DNA Cell Engineering — Concentration risk
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's cell engineering — concentration risk.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's cell engineering — concentration risk?
- Ginkgo Bioworks (DNA) reported cell engineering — concentration risk of 100% in Q1 2026.
- What does cell engineering — concentration risk mean?
- This metric assesses the overall exposure of the cell engineering segment to specific market sectors, technologies, or customer bases. It serves as a qualitative and quantitative measure of the potential impact that a downturn in a specific area could have on the segment's performance.